Cytek Biosciences, Inc. (CTKB) on GreekSoup https://greeksoup.ai/stocks/us/ctkb/ Every dated entry in the public record on Cytek Biosciences, Inc.: results, filings, insider trades and the rest, from the filings, the last 90 days. en Fri, 30 Oct 2026 00:00:00 +0000 Cytek Biosciences, Inc.: short interest 4,409,745 shares at the 15 October 2026 settlement, 2.68 days to coverhttps://greeksoup.ai/stocks/us/ctkb/short-interest/us:CTKB:short-interest:2026-10-15:868238ae3aThu, 15 Oct 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Cytek Biosciences, Inc.: short interest 5,215,595 shares at the 30 September 2026 settlement, 3.13 days to coverhttps://greeksoup.ai/stocks/us/ctkb/short-interest/us:CTKB:short-interest:2026-09-30:3de83331e8Wed, 30 Sep 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Cytek Biosciences, Inc. filed 8-K: charter or bylaw amendment, or fiscal year changehttps://greeksoup.ai/stocks/us/ctkb/filings/us:CTKB:filing:2026-09-29:486fedb4fcTue, 29 Sep 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Cytek Biosciences, Inc.: short interest 5,242,079 shares at the 15 September 2026 settlement, 5.74 days to coverhttps://greeksoup.ai/stocks/us/ctkb/short-interest/us:CTKB:short-interest:2026-09-15:621e4f04c2Tue, 15 Sep 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Cytek Biosciences, Inc.: Form 144, PHILIPPE BUSQUE plans to sell 31,666 shares worth $146,515 around 2 September 2026https://greeksoup.ai/stocks/us/ctkb/planned-sales/us:CTKB:planned-sale:2026-09-02:267d8d515aWed, 02 Sep 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Cytek Biosciences, Inc.: short interest 4,931,028 shares at the 31 August 2026 settlement, 6.64 days to coverhttps://greeksoup.ai/stocks/us/ctkb/short-interest/us:CTKB:short-interest:2026-08-31:ef3c5ba671Mon, 31 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Cytek Biosciences, Inc. filed 8-K: regulation fd disclosure, other eventshttps://greeksoup.ai/stocks/us/ctkb/filings/us:CTKB:filing:2026-08-24:fe4ad94695Mon, 24 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Cytek Biosciences, Inc.: short interest 4,989,610 shares at the 14 August 2026 settlement, 5.08 days to coverhttps://greeksoup.ai/stocks/us/ctkb/short-interest/us:CTKB:short-interest:2026-08-14:5ff16c28c6Fri, 14 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Cytek Biosciences, Inc.: Schedule 13G/A filed by Integrated Core Strategies (US) LLC, 7.2% of the classhttps://greeksoup.ai/stocks/us/ctkb/holders/us:CTKB:schedule-13:2026-08-06:565b284c3fThu, 06 Aug 2026 00:00:00 +0000Schedule 13D/13GSchedule 13D/13G. The filing. The page on GreekSoup.

]]> Cytek Biosciences, Inc. Q2 FY2026 results: revenue $48 million, net income -$12 millionhttps://greeksoup.ai/stocks/us/ctkb/results/fy2026-q2/us:CTKB:result:2026-08-05:2cb9735817Wed, 05 Aug 2026 00:00:00 +0000ResultsResults. The filing. The page on GreekSoup.

]]> Cytek Biosciences, Inc. filed 10-Q: 10-qhttps://greeksoup.ai/stocks/us/ctkb/filings/us:CTKB:filing:2026-08-05:31b107898aWed, 05 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Cytek Biosciences, Inc. filed 8-K: results of operationshttps://greeksoup.ai/stocks/us/ctkb/filings/us:CTKB:filing:2026-08-05:b4505a4563Wed, 05 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Cytek Biosciences, Inc.: Schedule 13G filed by Boston Partners, 5.9% of the classhttps://greeksoup.ai/stocks/us/ctkb/holders/us:CTKB:schedule-13:2026-08-04:6b0f4f1f55Tue, 04 Aug 2026 00:00:00 +0000Schedule 13D/13GSchedule 13D/13G. The filing. The page on GreekSoup.

]]>